Embody

Science that Moves You

Pioneering the next generation in
regenerative sports medicine solutions

Our Technology

Learn about Tapestry, our newest FDA cleared product Watch the Video

Do you want more information about Embody and what we do? Contact Us

Do you have questions about our technology? Contact Us

About Us

Progressing The Standard of Care

Embody, A Sports Medicine Company

Embody is pioneering the next generation regenerative platform with novel collagen- based biofabrication techniques and products for sports medicine.

2014

Developing innovative and restorative
medical products
since 2014.

2015

DARPA
awards Embody $11.85MM
to progress the standard of care.

2020

Embody launches its first product,
TAPESTRY, a
bioengineered tendon analog.

Learn more about our technology

60,000

Addressing Needs in Foot & Ankle

There are over 60,000 Achilles procedures performed in the US each year.
The biological effect of the TAPESTRY
Biointegrative Implant offers the potential
to address unmet needs in traditional Achilles repair
as well as challenging foot and ankle tendon procedures.

Learn more about TAPESTRY.

800,000

Augmenting Shoulder Procedures

There are over 800,000 Rotator Cuff procedures performed each year
with a high incidence of re-tear.
TAPESTRY® Biointegrative Implant is a biostimulative
collagen-based implant with bioengineered micro-architecture
specifically designed for tendon repair that supports soft tissue healing.

Learn more about TAPESTRY.

400,000

Future Adaptation to Knee Surgery

Embody’s proprietary biofabrication process precisely
controls the molecular assembly of collagen into
microfibers with unprecedented strength and modulus. With over
400,000 knee ligament repairs performed annually,
our microfluidics-based technology follows the body’s ability to
assemble collagen into strong, aligned fibers, as found in the native tissue.

Learn more about our technology.